Longitudinal neural connection detection using a ferritin‐encoding adeno‐associated virus vector and in vivo MRI method by Cai, A et al.
 
Longitudinal neural connection detection using a Ferritin-encoding Adeno-associated virus 1 
vector and in vivo MRI method 2 
Aoling Cai a, b, 1, Ning Zheng b, 1, Garth J. Thompson c, Yang Wu b, d, Binbin Nie e, Kunzhang Lin 3 
f, Peng Su f, Jinfeng Wu b, Anne Manyande g, Ling-Qiang Zhu h, Jie Wang b, d, i*, Fuqiang Xu a, b, d, 4 
f, j* 5 
a Wuhan National Laboratory for Optoelectronics, Huazhong University of Science and 6 
Technology, Wuhan, 430074, P.R. China. 7 
b Key Laboratory of Magnetic Resonance in Biological Systems, State Key Laboratory of 8 
Magnetic Resonance and Atomic and Molecular Physics, National Center for Magnetic 9 
Resonance in Wuhan, Wuhan Institute of Physics and Mathematics, Innovation Academy for 10 
Precision Measurement Science and Technology, Chinese Academy of Sciences-Wuhan 11 
National Laboratory for Optoelectronics, Wuhan, 430071, P.R. China. 12 
c iHuman Institute, ShanghaiTech University, Shanghai, 201210, P.R. China. 13 
d University of Chinese Academy of Sciences, Beijing, 100049, P.R. China. 14 
e Key Laboratory of Nuclear Radiation and Nuclear Energy Technology, Institute of High 15 
Energy Physics, Chinese Academy of Sciences, Beijing, 100049, P.R. China. 16 
f Shenzhen Key Lab of Neuropsychiatric Modulation, Guangdong Provincial Key Laboratory 17 
of Brain Connectome and Behavior, CAS Key Laboratory of Brain Connectome and 18 
Manipulation, the Brain Cognition and Brain Disease Institute (BCBDI), Shenzhen Institutes 19 
of Advanced Technology, Chinese Academy of Sciences; Shenzhen-Hong Kong Institute of 20 
Brain Science-Shenzhen Fundamental Research Institutions, Shenzhen, 518055, P.R. China. 21 
g School of Human and Social Sciences, University of West London, London, UK. 22 
h Department of Pathophysiology, Key Lab of Neurological Disorder of Education Ministry, 23 
School of Basic Medicine, Tongji Medical College, Huazhong University of Science and 24 
Technology, Wuhan, 430030, P.R. China. 25 
i Hebei Provincial Key Laboratory of Basic Medicine for Diabetes, 2nd Hospital of 26 
Shijiazhuang, Shijiazhuang, Hebei, 050051, P.R. China. 27 
j Center for Excellence in Brain Science and Intelligent Technology, Chinese Academy of 28 
Sciences, Shanghai, 200031, P.R. China. 29 
 30 
1 These authors contributed equally to this work. 31 
* Corresponding author 32 
Jie Wang, E-mail: jie.wang@wipm.ac.cn; Tel: +86-27-87187359; Fax: +86-27-87199543. 33 




The investigation of neural circuits is important for interpreting both healthy brain function and 37 
psychiatric disorders. Currently, the architecture of neural circuits is always investigated with 38 
fluorescent protein encoding neurotropic virus and ex vivo fluorescent imaging technology. 39 
However, it is difficult to obtain a whole-brain neural circuit connection in living animals, due to 40 
the limited fluorescent imaging depth. Herein, the non-invasive, whole-brain imaging technique of 41 
MRI and the hypotoxicity virus vector AAV (adeno-associated virus) were combined to investigate 42 
the whole-brain neural circuits in vivo. AAV2-retro are an artificially-evolved virus vector that 43 
permits access to the terminal of neurons and retrograde transport to their cell bodies. By expressing 44 
the ferritin protein which could accumulate iron ions and influence the MRI contrast, the neurotropic 45 
virus can cause MRI signal changes in the infected regions. For mice injected with the ferritin-46 
encoding virus vector (rAAV2-retro-CAG-Ferritin) in the caudate putamen (CPu), several regions 47 
showed significant changes in MRI contrasts, such as PFC (prefrontal cortex), HIP (hippocampus), 48 
Ins (insular cortex) and BLA (basolateral amygdala). The expression of ferritin in those regions 49 
were also verified with ex vivo fluorescence imaging. In addition, we demonstrated that changes in 50 
T2 relaxation time could be used to identify the spread area of the virus in the brain over time. Thus 51 
the neural connections could be longitudinally detected with the in vivo MRI method. This novel 52 
technique could be utilized to observe the viral infection long-term and detect the neural circuits in 53 
a living animal.  54 
 55 




The brain is the most complex organ in the body, and more than 70 billion neurons exist in the 59 
human brain to form a complicated network (Grandjean, et al., 2020). More and more preclinical 60 
studies have shown that neural networks play an essential role in instinctive behaviors such as fear 61 
(Wei, et al., 2015), reward (Zhang, et al., 2017) and mating (Wei, et al., 2018). In addition, the 62 
alteration of neural networks may lead to abnormal animal behaviors, such as epilepsy-like (Citraro, 63 
et al., 2013) or depression-like behaviors (Rozov, et al., 2001), suggesting that human brain diseases 64 
may emerge from neural network dysfunction. Dissecting neural networks is important for 65 
understanding brain function in a physiological or pathological state. 66 
Currently, neurotropic viral vectors have been widely used to investigate the neural networks. 67 
As a series of artificially modified neurotropic viruses, neurotropic viral vectors can transport 68 
exogenous genes along the synapses-connected neural networks. Numerous virus vectors were 69 
constructed to dissect the structure of neural networks after genetic modifications, such as herpes 70 
simplex virus (HSV), pseudorabies virus (PRV), rabies virus (RV), etc. (Nassi, et al., 2015; Rao and 71 
Wang, 2020; Ugolini, 2010). However, most of them can only be used for ex vivo imaging due to 72 
their virulence. Recombinant adeno-associated virus (rAAV) vectors are effective tools for 73 
exogenous gene delivery for living animal studies due to their advantages of high-level transgene 74 
expression and low cell toxicity (Kaplitt, et al., 2007). Recently an artificially-evolved AAV series 75 
vector (rAAV2-retro) was introduced to mediate retrograde access to neurons (Tervo, et al., 2016). 76 
It is a powerful tool to image neural circuits when combined with the fluorescent protein gene 77 
(Zheng, et al., 2020). However, due to limitation of the fluorescent imaging depth, it is hard to 78 
observe the whole-brain neural circuit in a living animal, which also impedes our understanding of 79 
 
the virus infection procedures. Thus, it was valuable to develop a novel method for in vivo neuronal 80 
network detection. 81 
A vast amount of impressive work has been done for living animal imaging. Near-infrared 82 
(NIR) fluorescence imaging methods have been used to increase the imaging depth of fluorescent 83 
protein (Frangioni, 2003) and allow for in vivo imaging (Hong, et al., 2017). However, the NIR 84 
signal is only reliable within the depth of 3 mm (Hong, et al., 2014). Luciferase has also been used 85 
as an in vivo imaging strategy because, with a highly sensitive detector, the imaging depth can be 86 
up to 40 mm. While this has been valuable for labeling cancer cells and gene expression (Li, et al., 87 
2017), the spatial resolution of luciferase imaging is not sufficient enough for tracing neural circuits 88 
(Cook and Griffin, 2003). Magnetic resonance imaging (MRI) is a commonly used clinical image 89 
technique, which has the advantages of non-invasive and large-scale imaging (Van Leemput, et al., 90 
2009; Wu, et al., 2003). The MRI also provides a good compromise of moderately high spatial 91 
resolution (~100 µm) while covering the entire brain (Pagani, et al., 2016; Ullmann, et al., 2013). 92 
Thus, with a proper MRI contrast agent encoded by the virus vector, MRI could be an excellent tool 93 
to trace the whole-brain neural networks in living animals. 94 
Ferritin is a ubiquitous iron storage protein found in most organisms. In general, it protects the 95 
cell from damaging active oxide Fe2+ and stores the iron ion in the shell of ferritin as Fe3+. As Fe3+ 96 
is a paramagnetic MRI contrast agent, the overexpression of ferritin is able to change the transverse 97 
magnetic relaxation rate (1/T2) of the surrounding tissue. Thus, at sufficiently high concentration 98 
and with sufficient access to biological iron, ferritin can change the contrast of the MRI signal and 99 
show its presence with hypointensity on T2-weighted MRI images (Iordanova and Ahrens, 2012; 100 
Wu, et al., 2018). In our previous work, the ferritin gene was loaded onto the  VSV (Vesicular 101 
 
stomatitis virus) and a multi-synaptic neural network connected to sensory cortex was illustrated 102 
(Zheng, et al., 2019). However, the result was obtained using ex vivo MRI due to the virulence of 103 
the VSV. Here, we tried to display the whole-brain neural network in a living animal with 104 
hypotoxicity virus vector AAV. 105 
Herein, a novel tool for in vivo whole-brain neural network imaging was developed. We loaded 106 
the ferritin gene onto a retrograde transporting AAV vector, delivered it to the caudate-putamen 107 
(CPu) of mice and imaged these mice with in vivo MRI. In doing so, we were able to visualize a 108 
CPu-connected network that includes the upstream brain regions sending projection to the CPu. The 109 
ferritin-encoding retrograde transporting AAV vector enabled the investigation of neural network in 110 
living animals and long-term observation of the virus infection.  111 
 112 
Results 113 
MRI signal changes of the regions with ferritin transduction 114 
Firstly, the function of rAAV2-retro-CAG-Ferritin to label the neural networks and express 115 
ferritin was investigated. To this end, a control virus vector rAAV2-retro-CAG-EGFP was 116 
constructed for comparison (Fig. 1A). These two virus vectors were injected into the CPu region of 117 
mice with similar titers (5*1012 vg/mL) and volumes (2.8 μL). Sixty days after receiving the 118 
injection the animals were firstly scanned with MRI. Then all animals were sacrificed and the brain 119 
slices were performed with immunohistochemical staining and fluorescence imaging. The brain 120 
slices of these two groups with same stereotaxic coordinates were chosen for comparison (Fig. 1B). 121 
Similar to the rAAV2-retro-CAG-EGFP infected group, the expression of ferritin could be found in 122 
multiple brain regions other than the injection site CPu, such as the PFC (prefrontal cortex), HIP 123 
 
(hippocampus), Ins (insular cortex), and BLA (basolateral amygdala). Most of those areas were 124 
directly connected to CPu (Tervo, et al., 2016). Secondly, the MRI signals were also compared in 125 
the whole brain of mice infected with these two virus vectors. In rAAV2-retro-CAG-Ferritin infected 126 
group, the hypointensity MRI signals (compared to the surrounding tissue) were observed at ferritin 127 
expressed regions (Fig. 1B, lower). Meanwhile, there was no discernible signal changes observed 128 
on the T2-weighted MRI image in the same regions with EGFP overexpression in the control group 129 
(Fig. 1B, upper). 130 
In order to dissect the neural circuit, the resolution and SNR (signal to noise ratio) of the MRI 131 
image should be sufficient enough to distinguish the structural regions or even the sub-regions of 132 
the brain. The fluorescence and MRI images of similar brain structures were expanded to illustrate 133 
the details of ferritin-encoding AAV expression (Fig. 2). For fluorescence imaging, the red 134 
fluorescent was used to illustrate the expression of ferritin and the changes in MRI signal intensity 135 
were regard as the MRI contrast effect caused by ferritin expression and iron ions aggregation. 136 
Overlapping with a stereotaxic atlas of the mouse brain (Paxinos and Franklin), the location of 137 
ferritin could be plainly identified. Seven representative regions with obvious ferritin expression 138 
were collected for comparison, such as CPu, BLA, HIP, PFC, Tha (Thalamus), Ins and posterior 139 
HIP (Fig. 2B). Although the resolution and SNR of the MRI were much lower than fluorescence 140 
imaging, the same ferritin expressing regions could be observed by both MRI and fluorescence 141 
imaging.  In addition, a more detailed brain partition map of the Ins region was used to explore 142 
whether subtle localized changes could be detected with in vivo MRI (Allen mouse brain atlas, 143 
http://atlas.brain-map.org/). Using this, the distribution of ferritin could be located in the fifth layer 144 
 
of the insular cortex. Thus, the subtle localized changes could also be detected using the MRI 145 
method.  146 
Long term observation of T2-weighted images with ferritin/EGFP expression 147 
The longitudinal recording of rAAV2-retro-CAG-Ferritin and rAAV2-retro-CAG-EGFP 148 
infected groups were performed at different time points (0d, 10d, 30d, 60d) in the same animal using 149 
T2-weighted MRI (Supplementary material, Fig. S1). Based on the fluorescent imaging, the changes 150 
in MRI contrasts of the virus infected areas could be longitudinally monitored, such as PFC, BLA, 151 
Ins, and HIP. In the rAAV2-retro-CAG-Ferritin group, the changes in MRI contrast of those regions 152 
were directly observed after 30 days’ infection and became stronger at 60 days. Meanwhile, there 153 
were no significant changes observed in the rAAV2-retro-CAG-EGFP group during the whole 154 
period of infection.  155 
To quantitatively measure changes in MRI contrast, six regions (CPu, PFC, BLA, Ins, HIP and 156 
Tha) with ferritin/EGFP expression were selected as ROIs (regions of interest) based on an open 157 
source MRI template (TMBTA), and the other two regions CSF (cerebrospinal fluid) and SC 158 
(superior colliculus) were chosen for comparison due to limited ferritin/EGFP expression 159 
(Supplementary material, Fig. S2). Signal intensity normalization (with CSF) were performed 160 
before statistical comparison, and the one-way ANOVA (LSD post hoc test) method was used to 161 
evaluate changes in signal intensity in the T2-weighted images following the infection days 162 
(Supplementary material, Fig. S3). In the rAAV2-retro-CAG-Ferritin infected group (0d, N=14; 10d, 163 
N=11, 30d, N=8; 60d; N=5), statistical differences in MRI contrast were observed in the virus 164 
infected regions following virus infection, such as CPu, BLA, HIP, PFC, Ins and Tha (p<0.05), 165 
while no significant signal changes were detected in SC among different infection time points. 166 
 
Moreover, there were no significant MRI signal changes in all these brain regions of the rAAV2-167 
retro-CAG-EGFP group during the entire virus infected periods (0d, N=3; 10d, N=3, 30d, N=3, 60d; 168 
N=3).  169 
Tracing CPu connected regions using changes in T2 relaxation time  170 
To show the neural network in vivo with a whole-brain view, voxel-wise changes in T2 171 
relaxation time were performed based on the normalized T2 relaxation time maps (Fig. 3A). The 172 
multi-echo T2-weighted images were converted to T2 relaxation time maps and then normalized to 173 
a standard space base on the transformation matrix of T2-weighted images. The differences between 174 
T2 relaxation time maps before injection (0d, Fig. 3B) and after injection (10d, 30d, 60d) were 175 
calculated voxel by voxel (Fig. 3B) and then filtered by a threshold of 4-15ms (Fig. 4).  176 
The mapping of T2 relaxation time changes was compared with fluorescent images and T2-177 
weighted images with similar brain structures. The comparisons among three different time points 178 
are illustrated (Fig. 4). Ten days after the injection, ferritin expression was observed in CPu and 179 
PFC with fluorescence imaging. The same regions were also detected in mapping of T2 relaxation 180 
time changes (10d), although the area was not as wide as the fluorescence imaging. Thirty days after 181 
infection, stronger signals were detected in PFC, CPu, Tha, BLA, HIP, and Ins from the fluorescence 182 
images, and wider signals were also found in PFC, CPu, BLA and Ins from the T2 relaxation time 183 
change mapping (30d). Sixty days after infection, the fluorescent signal spread across the whole-184 
brain through the fluorescence imaging, particularly in the PFC, CPu, Tha, BLA, HIP and Ins. 185 
Consistently, the T2 relaxation time change mapping (60d) showed more similar labeled patterns 186 
compared to the fluorescence imaging. Overall, similar signal tendency was obtained from both the 187 
fluorescence imaging and the T2 relaxation time change mappings over the four infected periods. 188 
 
Thus, the changes in T2 relaxation time can be used to identify in vivo the spreading area of the 189 
virus in the brain over time. 190 
Furthermore, the mapping of T2 relaxation time changes was utilized to investigate the CPu 191 
connected regions with the in vivo MRI approach in the same animal at different time points after 192 
the rAAV2-retro-CAG-Ferritin injection. The dynamic changes in MRI contrast were almost similar 193 
in all individual subjects (Fig. 5). During the early stage of virus infection (10d), changes in T2 194 
relaxation time was only observed at the injection site (CPu). Thirty days after the infection, more 195 
regions showed distinct changes in all the subjects, such as PFC, HIP and BLA. After 60 days, most 196 
of CPu single synapse connected regions were detected at the mapping of T2 relaxation time 197 
changes, such as PFC, BLA, Ins and Tha. Although the signals were unstable during the early stage 198 
of the infection, the changes in MRI contrast became stronger and more consistent after 60 days’ 199 
infection. Thus, this method could be a promising way for investigating the neural circuits in living 200 
animals. 201 
Quantification of T2 relaxation time changes in ferritin transduction regions 202 
 The T2 relaxation time of ferritin overexpressed regions were further quantitatively measured 203 
to assess the MRI signal change along with the infection periods. Six regions with ferritin 204 
overexpression (CPu, BLA, HIP, Ins, PFC and Tha) and two regions without ferritin overexpression 205 
(CSF and SC) were chosen for comparison (Supplementary material, Fig. S2). One-way ANOVA 206 
(LSD post hoc test) was used to test for changes in T2 relaxation time among eight regions as well 207 
as infection days (0d, N=14; 10d, N=11, 30d, N=8 60d; N=5). As shown in Fig. 6, there was no 208 
significant change in the T2 relaxation time detected at CSF or SC where no ferritin was 209 
overexpressed during the whole infection period (p>0.05, marked with same lowercase). Among 210 
 
the other six regions, significant changes were only found at CPu after 10 days’ infection (p<0.05, 211 
marked with different lowercase). When enough time was given for virus infection and ferritin 212 
expression, all six regions that ferritin overexpressed showed significant changes after 30 days’ 213 
infection compared to 0 days’ infection . More significant differences could be found in those 214 
regions after 60 days’ infection time compared to 0 days’ or 30 day’.  215 
 216 
Discussion 217 
Fluorescence imaging is one of the most commonly used method to visualize results of virus-218 
based neural circuit tracing. However, the depth of fluorescence imaging is always limited by the 219 
light transmittance of animal tissues. Although much effort has been made to improve the detection 220 
depth of animal fluorescence imaging, it is difficult to show the labeled regions in living animals 221 
with a whole-brain view (Cook and Griffin, 2003; Frangioni, 2003; Helmchen and Denk, 2005; Zhu, 222 
et al., 2020). Herein, the retrograde virus vector AAV that express MRI contrast protein (ferritin) 223 
was used to illustrate the neural network in living animals. By injecting the virus into the CPu, we 224 
observed a network that directly connected to the CPu using in vivo MRI during three different 225 
periods after the virus injection. Moreover, the network was confirmed by the fluorescence imaging 226 
method. This method could be a powerful approach for exploring the neural circuits in vivo. 227 
Resolution and SNR of MRI in dissecting neural circuits 228 
Although MRI has the advantages of non-invasive and large imaging scale, the resolution and 229 
signal-to-noise ratio are much lower than fluorescence imaging. For fluorescence imaging, the 230 
resolution could reach 0.2 µm, and there is little interference in the background. Since the diameter 231 
of neurons is usually ~5µm, the fluorescence imaging can easily distinguish the neuron cells 232 
 
(Cunnane, et al., 2019). In MRI it is hard to distinguish an individual neuron, due to limited 233 
resolution and SNR. However, the resolutions and SNR of MRI are sufficient to distinguish the 234 
brain regions for neuronal network detection. In the current study, the distributions of ferritin were 235 
always aggregated with significant boundaries, where the T2-weighted images could be utilized to 236 
distinguish the change in MRI contrast, such as BLA, Ins and HIP (Fig. 2). For the regions of PFC, 237 
CPu and Tha, it was not easy to distinguish the ferritin expressed regions from the T2-weighted 238 
images, due to the dispersive distribution of ferritin and the low signal intensity of the background. 239 
For these regions, the ROIs based statistics analysis of signal intensity and the changes in T2 240 
relaxation time were capable of illustrating the MRI contrast effect caused by ferritin expression. 241 
There were also some regions with lower fluorescence where the ferritin expression was weak and 242 
sparse. For these regions, it was very difficult to distinguish the change in T2-weighted MRI signal 243 
intensity. This was probably caused by the low SNR and resolution of MRI, as the weak and sparse 244 
ferritin expressions were not sufficient enough to generate the detectable MRI contrast. 245 
 246 
MRI signals at different infection times 247 
In these experiments, ferritin was overexpressed in a CPu related network through a AAV2-248 
retro virus vector, and three time points (10d, 30d, 60d) were selected to evaluate the ferritin 249 
expression and MRI signal. Different ferritin expressions and MRI signals were found at the three 250 
time points, and the characteristics of rAAV vector could be the main reason for the differences. The 251 
expression of AAV-carrying genes usually increases over time and reaches a plateau within 3-12 252 
weeks (Tenenbaum, et al., 2004) and most of the AAV2-retro labeled results are obtained within 3-253 
8 weeks as reported. Three weeks (Itoga, et al., 2019) and four weeks (Itoga, et al., 2019) are the 254 
 
most commonly used waiting time for AAV2-retro expression and it is reported that more labeled 255 
information can be obtained using eight weeks waiting time rather than four weeks (Cunnane, et al., 256 
2019).  257 
Comparing ferritin expression and MRI signals, incomplete synchronization was detected 258 
between ferritin expression and MRI signal changes, especially in the early stage of the virus 259 
infection. The incomplete synchronization probably results from the characteristics of ferritin. 260 
Ferritin itself is not an MRI contrast agent and it influences the MRI signal by recruiting iron ions. 261 
There are several parameters influenced by the recruiting iron ions: the quantity of ferritin expressed 262 
in the infected region, the distribution of ferritin in cells, the iron enrichment in the intracellular 263 
environment, the supplement rate of iron ions and the degradation rate of ferritin. These differences 264 
could be the source of the incomplete synchronization between ferritin expression and MRI signals 265 
at 10 days and 30 days after the injection. Moreover, the difference between these two signals 266 
became smaller when the infection time reached 60 days, as enough time was given to enrich the 267 
iron ions. Further work is needed to shorten the time delay between ferritin expression and MRI 268 
contrast generation, such as supplementing iron ions. 269 
Relationship between ferritin expression and MRI contrast 270 
Although ferritin is reported to recruit iron ions and influence the MRI signals, there were 271 
many factors that influence the MRI signal changes. Ferritin is an autologous protein which is 272 
involved in inflammation reaction (Namaste, et al., 2017), the infection of AAV could hypothetically 273 
lead to regional inflammation which could also cause overexpression of ferritin (Vande Velde, et al., 274 
2011). Therefore, the expression of ferritin in the infection of rAAV2-retro-CAG-EGFP was also 275 
investigated, and no obvious ferritin expression was found (Supplementary material, Fig. S4). 276 
 
Furthermore, Prussian Blue staining was also utilized to verify the accumulation of Fe3+. The blue 277 
complexes were found at the regions where ferritin was overexpressed (Supplementary material, 278 
Fig. S5). Thus, the change in MRI contrast mediated by infection of rAAV2-retro-CAG-Ferritin 279 
might have been caused by ferritin overexpression and Fe3+ accumulation, rather than inflammation. 280 
Degradation of ferritin could hypothetically cause ferroptosis (Xie, et al., 2016), leading to 281 
cell death when a mass of unbound iron ions are released to the cell. However, overexpression of 282 
ferritin can result in an iron-deficiency intracellular environment (Naumova and Vande Velde, 283 
2018), which could lead to the suppression of ferroptosis (Hou, et al., 2016). Prior studies also 284 
demonstrated that there is no obvious influence on cells when ferritin is overexpressed (Iordanova 285 
and Ahrens, 2012; Iordanova, et al., 2013). Other than ferroptosis, changes in iron balance of the 286 
surrounding tissue around the regions with ferritin overexpression are another potential concern. 287 
While this may be a concern for short time periods, iron deficiency could be rebalanced by the 288 
blood supply for long time tracing work (more than 10 days). Besides, the expression of apoptosis 289 
and inflammation marker, caspase-3 and Iba1, were tested, and no noticeable abnormalities were 290 
found in regions BLA, HIP and PFC, where ferritin was overexpressed (Fig. 7).  291 
Perspective and limitations 292 
Using the ferritin encoding virus, we observed the structural neural network in living mice for 293 
a long period after the virus injection. However, the entire neural network was presented in MRI 294 
images 60 days after the virus injection. At earlier time points only part of the network was displayed. 295 
Our future work could focus on shortening the latency time between the virus injection and MRI 296 
detection. Although the ferritin used in our experiment is already an MRI contrast enhanced version 297 
(Iordanova, et al., 2010), it is possible to make further improvements on the ferritin protein structure 298 
 
for better MRI contrast effect. Besides, exogenous iron ions supplements could be a possible method 299 
for providing better MRI contrast effect in shorter latency time (Vande Velde, et al., 2011). In 300 
addition, the ferritin-encoding virus and in vivo MRI could be used to investigate the expression 301 
levels of optogenetic (e.g. ChR2) or chemogenetic (e.g. hM3Dq or hM4Di) proteins encoded by a 302 
virus. Through MRI imaging, it is easier to know the spread and expression levels of the virus that 303 
can guide further manipulation or operation. For non-human primates or other big laboratory 304 
animals which are expensive and used for many years, it is important to know the transfected 305 
functional protein expression level, especially after a long time. This new technique will make it 306 
much easier to operate and reduce the usage of non-human primates or big animals in brain research. 307 
 308 
Materials and methods 309 
Animal preparation 310 
All animals involved in this study were treated in accordance with protocols approved by the 311 
Animal Ethics Committee at the Wuhan Institute of Physics and Mathematics, Chinese Academy of 312 
Sciences (approval number APM20016A). Male C57BL/6J mice (6–8 weeks old) were purchased 313 
from Hunan SJA Laboratory Animal Co., Ltd (Hunan, China) and allowed to acclimate three days 314 
before the experiment. All the animals were raised under 12h/12h light-dark cycle room with 315 
appropriate temperature, food and water were available ad libitum. 316 
Construction of Virus 317 
The rAAV2-retro-CAG-Ferritin and the rAAV2-retro-CAG-EGFP virus vector were packaged 318 
by a commercial company (BrainVTA, Wuhan, China). This virus will infect neurons in a network 319 
in a retrograde manner, moving from axon to soma. Briefly, the plasmids carrying exogenous genes 320 
 
and AAV2-retro packaging components were cotransfected into 293T cells. After three days’ 321 
cultivation, the AAV virions were collected and purified to a titer of 5-10*1012 vg/mL. In particular, 322 
the ferritin gene used in this experiment was a chimeric ferritin gene (L*H) which comes from the 323 
Mus musculus ferritin light chain and heavy chain (Gift from Prof. Xiaoming Li's lab in Zhejiang 324 
University). 325 
Stereotaxic injection 326 
Male C57BL/6J mice were anesthetized with 1.0% pentobarbital sodium (50 mg/kg) and fixed 327 
in a stereotaxic injection system (RWD, ShenZhen, China). The skull of each mouse was exposed 328 
after being locally anesthetized with lidocaine lincomycin gel (Xinya, Shanghai, China) and 329 
smeared with erythromycin eye ointment to prevent drying. A small hole about 1 mm in diameter 330 
was drilled in the skull to allow accessing the glass micropipette. The glass micropipette was 331 
stereotaxically injected into the CPu (Fig. 8, Caudate Putamen: 0.51 mm anterior to Bregma, 2 mm 332 
lateral from midline, 3.3 mm depth relative to Bregma) based on the stereotaxic coordinates of the 333 
mouse brain atlas (Paxinos and Franklin). Then, the virus suspension (2.8 μL) with titration of 5-334 
10*1012 vg/mL was infused into the CPu at a rate of 0.14 μL/min. After the injection, the 335 
micropipette was kept at the injection site for 10 min to prevent reflux and then it was slowly 336 
withdrawn. The head skin was surgical sutured after treatment with lidocaine lincomycin gel. At the 337 
end of the experiment, the animal was recovered from anesthesia on the heating pad and returned to 338 
its home cage. 339 
MRI scanning 340 
The in vivo MRI experiment was performed using a 7.0 Tesla Biospec small animal magnetic 341 
resonance imaging system (Bruker, Ettlingen, Germany). The animals were initially anesthetized 342 
 
with 4.0-5.0% isoflurane (RWD, Shenzhen, China) for induction and 1.0-1.5% for maintenance with 343 
a mixture of 30% O2 and 70% N2. The body temperature of animals was maintained with a 344 
thermostatic water cycle system under the animal bed. The breathing rate of the animal was 345 
monitored and maintained at 60±15 breaths/min to achieve the state of deep anesthesia. In addition, 346 
two ear bars and a tooth bar were used to minimize motion effect of MRI data acquisition. A 20cm 347 
birdcage coil was used for transmission, combined with a 20 mm surface coil for receiving (Bruker, 348 
Ettlingen, Germany). Multi-echo T2-weighted anatomical images were obtained using an MSME 349 
sequence (TR = 3000 ms; Effective TEs = 11, 22, 33, 44, 55, 66 ms; Number of Averages = 6; FOV 350 
= 17.5 *17.5 mm2; Slice thickness = 0.5 mm; Spatial resolution, 0.137 mm *0.137 mm). The T2 351 
relaxation time maps were obtained by processing the MSME image using Paravision 5.0 software 352 
(Bruker, Germany).  353 
The expression of the rAAV2 in living animals can last for more than two months and its 354 
expression can reach a maximal level after 30 days (Cunnane, et al., 2019). Thus, MRI scans were 355 
performed at four time points to study the longitudinal effects of the virus infection. The time points 356 
were: the day before the virus injection (0d, n=14), 10 days (10d, n=11), 30 days (30d, n=8) and 60 357 
days after injection (60d, n=5), respectively. The number of animals was reduced by 3 in each 358 
succeeding group as 3 animals were euthanized for the fluorescence study at each time point. 359 
Fluorescence imaging and immunohistochemistry 360 
Virus-infected mice were anesthetized with 1.0% pentobarbital sodium (50 mg/kg) and cardiac 361 
perfusion was applied with 0.9% saline followed by 4% paraformaldehyde solution. The brain was 362 
extracted and dehydrated with 30% (w/v) sucrose solution. After that, the dehydrated brain was 363 
 
sectioned into 40 μm slices using freezing microtome (Leica, German) and one of twelve slices were 364 
selected for fluorescence imaging (approach to the MRI slice thickness 0.5 mm). 365 
For the imaging of EGFP, the fluorescence imaging was directly performed. For the imaging 366 
of ferritin, caspase3, Iba1 or cell nucleus, immunohistochemistry staining was performed before the 367 
fluorescence imaging. For immunohistochemistry, the slices were first rinsed with PBS and then 368 
blocked with blocking solution buffer (PBS+0.3% TritonX-100+10% goat serum, 37℃, 1h). For 369 
ferritin staining, the rabbit anti-ferritin light chain antibody (Abcam, ab69090, UK) and Cy3-labeled 370 
goat anti-rabbit secondary antibody were utilized. For caspase3 staining, the rabbit anti anti-371 
caspase3 antibody (Cell Signaling Technology, #9661) and 488-labeled goat anti-rabbit IgG were 372 
used. For Iba1 staining, the goat anti anti-Iba1 antibody (Abcam, ab5) and Cy3-labeled donkey anti 373 
goat antibody were utilized. For cell nucleus staining, the fluorescent dye DAPI was used.  374 
For fluorescence imaging, the brain slices were transferred to microslide and scanned with an 375 
Olympus VS120 virtual microscopy slide scanning system (Olympus, Japan). For the filters, Leica 376 
U-MRFPHQ fluorescence mirror unit was used for the red fluorescence imaging, which included a 377 
535-555nm excitation filter, a 575-625nm emission filter and a 565nm dichromatic mirror; Leica 378 
U-MWIBA3 fluorescence mirror unit was used for green fluorescence imaging, which included a 379 
460-495nm excitation filter, a 510-550nm emission filter and a 505nm dichromatic mirror. 380 
Furthermore, the Perls' Prussian Blue staining method was utilized to verify the accumulation 381 
of iron ions. It was performed following a previous study (Kim, et al., 2010) with a commercial 382 
staining kit (Solarbio, G1422, Beijing, China). 383 
Data analysis 384 
 
The T2-weighted images and T2 relaxation time maps were transformed to NIFTI format using 385 
Bru2anz (Bruker, Germany). MRI images were normalized to a homemade mouse MRI template 386 
using spm12 (www.fil.ion.ucl.ac.uk). The heavily T2-weighted images (TE/TR = 55ms/3000ms) 387 
were used to show the MRI signal change in ferritin expressed regions (Fig. 8).  388 
For comparison between MRI images and fluorescence images, similar brain slices were 389 
chosen based on structural features and the slice position. The anterior commissure was used for 390 
feature recognition and the slice with the same axial distance from the anterior commissure was 391 
used for these comparisons. The MRI images and fluorescence images were matched with the mouse 392 
brain atlas. 393 
For calculating the variation within T2 relaxation times, all the T2 relaxation time maps firstly 394 
used nonlinear transformation to determine a homemade mouse brain template with spm old-395 
normalise. The T2 relaxation times mapping was obtained by comparing the T2 relaxation time map 396 
to the map from the same animal before injection (0d) (Fig. 3). The T2 relaxation time changes 397 
higher than 15ms or lower than 4ms were considered as outliers and deleted.  398 
To quantitatively describe changes in T2 relaxation times, all the MRI images were normalized 399 
to a publicly available mouse brain template TMBTA (www.nitrc.org/projects/tmbta_2019) and 400 
smoothed. Six regions with ferritin expression (CPu, HIP, BLA, Ins, PFC, Tha) and two regions 401 
without ferritin expression (SC, CSF) were chosen as ROIs based on the TMBTA mouse brain atlas 402 
(Supplementary material, Fig. S2). The average T2 relaxation times for the eight ROIs were 403 
obtained and these average values were compared using one-way ANOVA. Least significant 404 
difference (LSD) was used for post hoc multiple comparisons, with statistical significance at p<0.05. 405 
Data availability 406 
 
All data and the implementation code in this article are available upon request from the 407 
corresponding author (jie.wang@wipm.ac.cn). 408 
 409 
Conclusion 410 
We developed a novel neural network tracing method using a combination of in vivo MRI and 411 
virus tracing techniques. It enabled the detection of the neural network in a living animal with a 412 
whole-brain view. Besides, we measured the virus infection progress over a period of time in the 413 
same animal. This technology provides a totally different perspective for our understanding of the 414 
neural network. It may lead to a different explanation of the brain network when combining the 415 
results of in vivo virus tracing and in vivo detection technologies. The technology may also benefit 416 
the neural circuit tracing in animals with larger-size brains, of which the whole-brain fluorescence 417 
imaging is tremendous amount of work, but easy when using MRI. 418 
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Figure Legend 545 
 546 
Fig. 1. Detection of EGFP/Ferritin expression with fluorescence imaging and T2-weighted MRI 547 
(TE=55ms), 60 days after the virus injection. A: Virus genomes of rAAV2-retro-CAG-EGFP and rAAV2-548 
retro-CAG-Ferritin, Ftl1: Mus musculus ferritin light chain, Fth1: Mus musculus ferritin heavy chain. B: 549 
Upper, fluorescence images (green, EGFP) and corresponding MRI images (grey) of one representative 550 
mouse brain infected with rAAV2-retro-CAG-EGFP; Lower, fluorescence images (red, Ferritin) and 551 
corresponding MRI images (grey) of one representative mouse brain infected with rAAV2-retro-CAG-552 
Ferritin. 553 
 554 
Fig. 2. Signal comparison of the fluorescence imaging and MRI with brain region segmentation. A: the 555 
sketch map of virus infected regions after the rAAV2-retro injection (shown in fluorescence image). B: 556 
The distribution of Ferritin expression (red) and MRI signal changes (dark) compared at seven regions, 557 
CPu, BLA, HIP, PFC, Tha, Ins and post HIP. The mouse brain stereotaxic atlas is overlapped (white) to 558 
distinguish the brain structure. 559 
 560 
Fig. 3. The schematic diagram of the processing of multi-Echo T2-weighted images, and the calculation 561 
of T2 relaxation time change mapping. A: The multi-Echo T2-weighted images were firstly transformed 562 
to the T2 relaxation time map and then normalized to a template. The normalized T2 relaxation time 563 
maps (right) were subtracted with the map of 0d (left) and then screened with a threshold to form a T2 564 
relaxation time change mapping. B: The voxel-by-voxel T2 relaxation time change mappings in different 565 
infection periods. 566 
 
 567 
Fig. 4. The comparison of fluorescence image, T2 relaxation change mapping and T2-weighted image 568 
on a different infection day. Three time points after injection are shown (10d, 30d, 60d). Fluorescence 569 
images (top) are displayed to show the location and expression quantity of Ferritin at different time 570 
points. Corresponding images of the T2 relaxation time change mapping (middle) and the T2-weighted 571 
images (bottom) are displayed for comparison. The voxels in T2 relaxation time change mappings are 572 
shown with pseudo color (red-yellow) when the value is between 4ms and 15ms. Data was obtained from 573 
three different representative mice, as the fluorescence imaging was obtained from brain slices. 574 
 575 
Fig. 5. The longitudinal study of the rAAV2-retro-CAG-Ferritin infection at three different time points 576 
(10d, 30d, 60d) using in vivo MRI. The change in T2 relaxation times before versus after virus injection 577 
are used to represent the infected regions of the virus at three time points. The voxels in T2 relaxation 578 
time change mappings are shown with pseudo color (red-yellow) when the value is between 4ms and 579 
12ms. 580 
 581 
Fig. 6. Statistics analysis of T2 relaxation times at different time points after rAAV2-retro-CAG-Ferritin 582 
injection (0d, 10d, 30d, 60d). The T2 relaxation times of six ferritin expressed regions (CPu_R, BLA_R, 583 
HIP_R, Ins_R, PFC_R and Tha_R) and two negative control regions without ferritin expressed (CSF and 584 
SC) were extracted for comparison. Note: Significant changes among the four time points were calculated 585 
using one-way ANOVA with LSD post hoc test, and significant differences between each time point are 586 
illustrated with lowercase letters a, b, c, d (a different letter represented p<0.05 and the same letter 587 
represented p>0.05). 588 
 
 589 
Fig. 7. The expression of caspase-3 and Iba1 was investigated at the regions that ferritin was 590 
overexpressed (red, left). For caspase-3 staining (green, middle), obvious caspase-3 expression can only 591 
be observed at the injection site (CPu), and no signal was found at the other three regions (BLA, HIP, 592 
and PFC). For Iba1 staining (red, right), no abnormality was observed in the morphology and distribution 593 
of microglia. 594 
 595 
Fig. 8. Illustration of the schedule of the experiment.  596 
